<?xml version="1.0" encoding="UTF-8"?>
<p>In recent studies, chimeric antibodies, containing both human and mouse antibody sequences, have been developed by hybridoma technology to treat and prevent the new types of human coronavirus MERS-CoV and SARS-CoV-2 associated diseases (Berry et al., 2004; Widjaja et al., 2019; Wang et al., 2020). </p>
